Correlation Between the VerifyNow P2Y12 Assay and the Newly Developed APAL System in Neuroendovascular Patients.

CONCLUSIONS: The APAL system exhibits moderate correlation with PRU and % inhibition. APAL testing is a good choice for a clinical laboratory already in possession of Sysmex CS series analyzers. In this setting, APAL testing can significantly decrease the cost of platelet function testing for patients on antiplatelet therapy.
PMID: 32826246 [PubMed - as supplied by publisher]

Source: Annals of Clinical and Laboratory Science - June 30, 2020 Category: Laboratory Medicine Authors: Uematsu K, Sakayori T, Ishida H, Omori Y, Kitano K, Matsubara H, Enomoto Y Tags: Ann Clin Lab Sci Source Type: research